The research collaboration will apply genomic tumor profiling to identify prostate cancer patients undergoing active surveillance who may benefit from treatment with enzalutamide.
Read MoreA study has shown that Decipher Biopsy may accurately risk-stratify men for metastatic failure after first-line radiation and androgen deprivation therapy.
Read More
The award will be used to investigate the use of RNA extracted from urine for clinical diagnostic assays.
Read More
In blood samples from prostate cancer patients, researchers have found a group of circulating tumor cells that are linked to the spread of the disease.
Read More
The studies will examine whether large-scale RNA profiling can predict a patient’s response to first- or second-line treatments in bladder, kidney, and prostate cancers.
Read More